CN101979077A - Traditional Chinese medicine for treating heart cerebrovascular diseases - Google Patents
Traditional Chinese medicine for treating heart cerebrovascular diseases Download PDFInfo
- Publication number
- CN101979077A CN101979077A CN2010105402224A CN201010540222A CN101979077A CN 101979077 A CN101979077 A CN 101979077A CN 2010105402224 A CN2010105402224 A CN 2010105402224A CN 201010540222 A CN201010540222 A CN 201010540222A CN 101979077 A CN101979077 A CN 101979077A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- blood
- traditional chinese
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating heart cerebrovascular diseases. The traditional Chinese medicine is prepared from the following medicinal raw materials by weight: 30 to 60 grams of szechuan lovage rhizome, 30 to 60 grams of dragon's blood, 25 to 50 grams of notoginseng root, 60 to 100 grams of root of red-rooted salvia, 30 to 60 grams of raw leech, 30 to 60 grams of tuber, 60 to 100 grams of earthworm, and 15 to 40 grams of borneol. The medicinal raw materials are ground into fine powder to be prepared into capsules or tablets; and a patient takes 10 grams of traditional Chinese medicine for three times a day. The traditional Chinese medicine has the effects of reducing blood fat and blood pressure, removing thrombosis, and improving blood circulation, is mainly used for treating cardiovascular diseases, such as coronary heart disease, angina pectoris, myocardial ischemia and the like, and the cerebrovasular diseases, such as apoplexy, cerebral thrombosis, cerebral infarction, encephalatrophy, chronic cerebral circulation insufficiency, cerebral hemorrhage sequela, and the like, has short course of the treatment, quick response, and does not have resistance to medicament, and toxic or side effect; and total effective rate is up to 100 percent.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease.
Background technology
Cardiovascular and cerebrovascular disease is meant the disease that causes the heart and brain tissues blood supply disorder because of cardio cerebrovascular affection, and heart disease mainly shows as coronary heart disease and angina pectoris.Cerebrovascular mainly shows as hemorrhagic apoplexy and ischemic cerebrovascular.Current, cardiovascular and cerebrovascular diseases such as cerebral arteriosclerosis, coronary heart disease, angina pectoris, cerebral thrombosis, cerebral infarction, cerebral hemorrhage have become healthy frequently-occurring disease of a kind of serious harm person in middle and old age and common property disease.Therefore the control of cardiovascular and cerebrovascular disease has become the problem of society and medical circle extensive concern.Treat the compound medicines function singleness of cardiovascular and cerebrovascular disease at present, drug matching is mixed and disorderly, take effect slowly, and Western medicine can only be taked the way of blood vessel dilating, can only temporaryly alleviate, and cures the symptoms, not the disease, and the expense costliness, make the cardiovascular and cerebrovascular vessel patient be difficult to cure.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, short treating period, instant effect, no Drug resistance and toxic and side effects.
Medicament selection Radix Notoginseng of the present invention, Sanguis Draxonis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Pheretima, Radix Curcumae, unprocessed leech, Borneolum Syntheticum make up.Make each efficacy of drugs produce synergism the said medicine combination, thereby can effectively treat cardiovascular and cerebrovascular disease.
Choice of drug Radix Notoginseng of the present invention, Sanguis Draxonis, Rhizoma Chuanxiong are monarch drug, with promoting blood circulation to remove blood stasis, and promoting the circulation of QI to relieve pain, the molten bolt that purifies the blood expands blood vessel, accelerates blood circulation.The Radix Notoginseng anastalsis is extensive, again can blood stasis dispelling, and the upright motionless blood of invigorating blood circulation, the merit of the stasis of blood is not stayed in hemostasis, and " beautiful Chinese catalpa medicine is separated " claims that it can " with battalion's hemostasis, the clots absorbing of promoting blood circulation "; Sanguis Draxonis sweet in the mouth, salty, property are flat, go into the heart, liver, gallbladder meridian, and the congestion that stagnates is removed in the clots absorbing pain relieving; The Rhizoma Chuanxiong acrid in the mouth, warm in nature, go into liver, gallbladder, heart channel, blood-activating and qi-promoting.With Radix Salviae Miltiorrhizae, Pheretima, Radix Curcumae is ministerial drug, and wherein Radix Salviae Miltiorrhizae bitter in the mouth cold nature is gone into the heart, liver two warps, and promoting blood circulation to disperse blood clots and relieves pain is held concurrently during Compendium of Material Medica claims its " broken stagnated blood, mend fresh blood " to have to live and supported, and blood stasis dispelling is the length of blood trouble not; The Pheretima salty in the mouth is cold in nature, goes into liver, spleen, lung meridian, collateral dredging, blood pressure lowering; The Radix Curcumae acrid in the mouth is cold in nature, goes into the heart, Liver Channel, promoting QI circulation for relieving depression, and anti-blood clotting stasis, removing heat from blood purifies the blood.With Hirudo, Borneolum Syntheticum is adjuvant, and Hirudo salty in the mouth hardship, property are put down, and the merit of removing blood stasis dysmenorrhea is arranged; Borneolum Syntheticum acrid in the mouth bitterness is cold, causing resuscitation with aromatic drugs, refreshment, clearing away heat to alleviate pain.Modern pharmacological research proves: Radix Notoginseng has antithrombotic, regulates immunity promotion hemopoietic, effects such as blood vessel dilating; Radix Salviae Miltiorrhizae has heart tonifying, coronary dilating, increase scheming blood flow, antithrombotic formation, microcirculation improvement effect; Pheretima has thrombolytic, anticoagulant, arrhythmia and sedation; Hirudo has anticoagulant, thrombolytic, blood fat reducing, increases effects such as scheming blood nutrition.
Chinese medicine of the present invention is made by the crude drug of following weight ratio:
Rhizoma Chuanxiong 30-60 gram, Sanguis Draxonis 30-60 gram, Radix Notoginseng 25-50 gram, Radix Salviae Miltiorrhizae 60-100 gram, unprocessed leech 30-60 gram, Radix Curcumae 30-60 gram, Pheretima 60-100 gram, Borneolum Syntheticum 15-40 gram.
Preparation method: pulverization is made capsule or is made tablet according to a conventional method or other dosage forms.Use Chinese medicine of the present invention, blood vessel dilating, the anticoagulant thromboembolism preventing, thrombolysis and thrombus diminishing, change bolt row bolt, activate self streptokinase, blood fat reducing, fall blood viscosity, cholesterol reducing, blood pressure lowering, mediation blood vessels, improve blood circulation, cure mainly that coronary heart disease, angina pectoris, scheming ischemia, scheming infarction, arrhythmia, atrium antiperspirant are quivered, cardiovascular disease such as cardiopalmus heart beating, chest pain are weak, sensation of oppression over the chest with shortness of breath, premature beat, vexed insomnia, night sweat and paroxysmal pareordia breastbone pain.Diseases such as cerebrovascular disease such as apoplexy, cerebral thrombosis, cerebral embolism, cerebral infarction, brain atrophy, cerebral blood supply insufficiency, apoplexy sequela, hemiplegia, hyperlipidemia, hypertension, high blood viscosity are thick, hypercholesterolemia, arteriosclerosis all have obvious curative effects.
The specific embodiment
Preferred Rhizoma Chuanxiong 50 grams, Sanguis Draxonis 50 grams, Radix Notoginseng 30 grams, Radix Salviae Miltiorrhizae 80 grams, unprocessed leech 50 grams, Radix Curcumae 50 grams, Pheretima 80 grams, Borneolum Syntheticum 30 grams.Pulverization is made capsule or is made tablet, takes for 10 gram every days 3 times at every turn.
Below, further set forth the beneficial effect of Chinese medicine of the present invention by clinical observation experiment.
The present invention treats 300 routine cardiovascular and cerebrovascular vessel patients altogether, clinical symptoms: angina pectoris, uncomfortable in chest, apoplectic hemiplegia, aphasia, facial hemiparalysis, hemiplegia, veiny recovers gradually after one week of medication, month person of medication generally recovers self care ability fully, walking is normal, and it is normal to speak, and facial hemiparalysis is no more than a week recovers normal, blood pressure is kept normally, no sequel.Cure rate reaches 98%, and total effective rate reaches 100%.
1, the present invention treats the clinical experiment report of 100 routine coronary heart disease and patient with angina pectoris altogether, clinical symptoms: uncomfortable in chest, feel suffocated, angina pectoris, through clothes Chinese medicine of the present invention, 12 hours by having palpitation of causing of coronary heart disease, breathe hard, symptom such as uncomfortable in chest obviously alleviates, anginal symptom is improved rapidly, generally takes 3-10 days symptoms and obviously alleviates blood pressure stabilization, take 1-2 the course of treatment, symptom disappears substantially.Cure rate 98%, total effective rate reaches 100%.
2, the present invention treats cerebral thrombus patient's 100 examples, sign: consciousness, visual disorder, paresis or hemiplegia, inclined to one side side sensory disturbance, speech disorder, movement disorder, taking Chinese medicine of the present invention was clearly better after 30 days, trick is strong, and the hemiptegic can walk, and it is normal that verbal function recovers, after taking 2-3 the course of treatment, the body language function is recovered fully, cure rate 98%, and total effective rate reaches 100%.
3, treatment by Chinese herbs cerebral arteriosclerosis 100 examples of the present invention, clinical manifestation: comprise neurasthenia symptom, as dizziness, headache, hypomnesis, ability to work decline and autonomic nervous dysfunction etc.The cerebral arteriosclerosis dementia mainly shows as nerve, affective disorder.Patient's symptom after taking medicine sign disappears or the person's of having clear improvement 98 examples, and effectively, patient's symptom obviously alleviates, sign is improved or clinical symptoms sign disappearance person 2 examples, invalid 0 example, and cure rate reaches 98%, and total effective rate reaches 100%.
Claims (3)
1. Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, it is characterized in that: make Rhizoma Chuanxiong 30-60 gram, Sanguis Draxonis 30-60 gram, Radix Notoginseng 25-50 gram, Radix Salviae Miltiorrhizae 60-100 gram, unprocessed leech 30-60 gram, Radix Curcumae 30-60 gram, Pheretima 60-100 gram, Borneolum Syntheticum 15-40 gram by following materials of weight proportions medicine.
2. a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 1, it is characterized in that: make Rhizoma Chuanxiong 50 grams, Sanguis Draxonis 50 grams, Radix Notoginseng 30 grams, Radix Salviae Miltiorrhizae 80 grams, unprocessed leech 50 grams, Radix Curcumae 50 grams, Pheretima 80 grams, Borneolum Syntheticum 30 grams by following materials of weight proportions medicine.
3. a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 1 is characterized in that: preparation method is that the crude drug pulverization is made capsule or made tablet according to a conventional method or other dosage forms.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105402224A CN101979077B (en) | 2010-11-11 | 2010-11-11 | Traditional Chinese medicine for treating heart cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105402224A CN101979077B (en) | 2010-11-11 | 2010-11-11 | Traditional Chinese medicine for treating heart cerebrovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101979077A true CN101979077A (en) | 2011-02-23 |
| CN101979077B CN101979077B (en) | 2011-09-21 |
Family
ID=43599633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105402224A Expired - Fee Related CN101979077B (en) | 2010-11-11 | 2010-11-11 | Traditional Chinese medicine for treating heart cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101979077B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104587398A (en) * | 2015-01-20 | 2015-05-06 | 李兴尧 | Microorganism fermented traditional Chinese medicinal preparation as well as preparation method and application thereof |
| CN105106851A (en) * | 2015-09-17 | 2015-12-02 | 黑龙江省济仁药业有限公司 | Traditional Chinese medicine composition for treating coronary heart disease and preparing method thereof |
| CN113499414A (en) * | 2021-08-27 | 2021-10-15 | 威海德尚医中医药科技有限公司 | A Chinese medicinal composition for thrombolysis and preventing cardiovascular diseases, and its preparation method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101507765A (en) * | 2009-03-24 | 2009-08-19 | 杜枭非 | Medicine for treating cerebrovascular disease and sequela thereof and preparation method thereof |
-
2010
- 2010-11-11 CN CN2010105402224A patent/CN101979077B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101507765A (en) * | 2009-03-24 | 2009-08-19 | 杜枭非 | Medicine for treating cerebrovascular disease and sequela thereof and preparation method thereof |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104587398A (en) * | 2015-01-20 | 2015-05-06 | 李兴尧 | Microorganism fermented traditional Chinese medicinal preparation as well as preparation method and application thereof |
| CN105106851A (en) * | 2015-09-17 | 2015-12-02 | 黑龙江省济仁药业有限公司 | Traditional Chinese medicine composition for treating coronary heart disease and preparing method thereof |
| CN105106851B (en) * | 2015-09-17 | 2018-12-04 | 黑龙江省济仁药业有限公司 | The Chinese medicine composition and preparation method thereof for treating coronary heart disease |
| CN113499414A (en) * | 2021-08-27 | 2021-10-15 | 威海德尚医中医药科技有限公司 | A Chinese medicinal composition for thrombolysis and preventing cardiovascular diseases, and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101979077B (en) | 2011-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101020028B (en) | Chinese medicine for treating cardiac and cerebral vascular diseases | |
| CN101254272B (en) | Medicament for promoting coronary circulation and embolism resistance | |
| CN103083400A (en) | Drug for treating cardiovascular disease | |
| CN101979077B (en) | Traditional Chinese medicine for treating heart cerebrovascular diseases | |
| CN101306169B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease | |
| CN1176730C (en) | Chinese medicine health pillow | |
| CN101637571B (en) | Traditional Chinese medicine preparation for treating heart cerebrovascular diseases and preparation method thereof | |
| CN104001162A (en) | Medicament for treating cardiac neurosis and preparation method thereof | |
| CN1868527A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN103202995B (en) | Traditional Chinese medicine for treating myocardial infarction | |
| CN102526503A (en) | Medicament for treating cerebral infarction and preparation method thereof | |
| CN102423422B (en) | Chinese medicinal composition for treating cervical syndrome | |
| CN103120769A (en) | Medicine for treating cerebral circulation insufficiency | |
| CN101884737B (en) | Chinese medicinal composition for treating hemiparalysis | |
| CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
| CN109758538A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating apoplexy sequelae | |
| CN104288200A (en) | Medicine for treating cerebral thrombosis sequelae and preparation method thereof | |
| CN103432200B (en) | A kind of medicine for the treatment of Orthopeadic Surgery disease | |
| CN1279951C (en) | Pure Chinese traditional medicine capsule for treating hyperthyroidism and simple goiter | |
| CN102139005A (en) | Medicine for treating cardiovascular and cerebrovascular diseases | |
| CN102423339A (en) | Drug for treating cadiovascular and orthopaedics diseases | |
| CN106474359A (en) | A kind of medicine treating cerebrovascular | |
| CN105079502A (en) | Medicine for treating middle and terminal hypertension | |
| CN103990049A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN1238004C (en) | Instant particles 'Tongmaihuonao' for invigorating pulse beat and promoting circulation of cerebral blood |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110921 Termination date: 20131111 |